Back to mobile site

Aditxt acquires Ignite Proteomics for $36 million in cancer testing deal

March 13, 2026 8:15 AM EDT Send to a Friend
Aditxt Inc. (NASDAQ: ADTX) acquired Ignite Proteomics LLC for $36 million in preferred stock to expand its cancer diagnostic capabilities ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login